Established risk factors |
|
Previous acute GVHD, HLA disparities, recipient’s and donor’s age, peripheral blood stem cells, T-cell replete graft, controversial risk factors, male recipient/multiparous female donor, cord blood stem cells, viral infection, conditioning regimen |
62 |
Prognostic factors |
62 |
|
Thrombocytopenia, type of disease onset (progressive and overlap syndrome), extensive skin involvement, elevated bilirubin, lung involvement, gastrointestinal involvement (diarrhea), decreased performance status |
Prognostic classifications |
18 |
Limited vs extensive |
79, 81 |
Johns Hopkins Hospital |
59 |
Center for International Blood and Marrow Transplant Research |
61, 63 |
NIH consensus classification |
4 |